281 related articles for article (PubMed ID: 18717707)
21. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.
Vidović D; Carlon MS; da Cunha MF; Dekkers JF; Hollenhorst MI; Bijvelds MJ; Ramalho AS; Van den Haute C; Ferrante M; Baekelandt V; Janssens HM; De Boeck K; Sermet-Gaudelus I; de Jonge HR; Gijsbers R; Beekman JM; Edelman A; Debyser Z
Am J Respir Crit Care Med; 2016 Feb; 193(3):288-98. PubMed ID: 26509335
[TBL] [Abstract][Full Text] [Related]
22. Genetic modification of cells for transplantation.
Lai Y; Drobinskaya I; Kolossov E; Chen C; Linn T
Adv Drug Deliv Rev; 2008 Jan; 60(2):146-59. PubMed ID: 18037530
[TBL] [Abstract][Full Text] [Related]
23. Gene therapy for epilepsy.
McCandless DW; McCandless JW
Metab Brain Dis; 2010 Sep; 25(3):363-6. PubMed ID: 20862604
[No Abstract] [Full Text] [Related]
24. Recombinant adeno-associated virus type 2-mediated gene transfer into human keratinocytes is influenced by both the ubiquitin/proteasome pathway and epidermal growth factor receptor tyrosine kinase.
Braun-Falco M; Eisenried A; Büning H; Ring J
Arch Dermatol Res; 2005 May; 296(11):528-35. PubMed ID: 15776248
[TBL] [Abstract][Full Text] [Related]
25. In Vitro Evaluation of AAV Vectors for Retinal Gene Therapy.
Wagner JE; Schön C; Becirovic E; Biel M; Michalakis S
Methods Mol Biol; 2019; 1834():383-390. PubMed ID: 30324456
[TBL] [Abstract][Full Text] [Related]
26. Gene therapy in epilepsy.
Zhang L; Wang Y
Biomed Pharmacother; 2021 Nov; 143():112075. PubMed ID: 34488082
[TBL] [Abstract][Full Text] [Related]
27. Development and use of gene transfer for treatment of cardiovascular disease.
Baker AH
J Card Surg; 2002; 17(6):543-8. PubMed ID: 12643466
[TBL] [Abstract][Full Text] [Related]
28. Adeno-associated virus (AAV) as a vehicle for therapeutic gene delivery: improvements in vector design and viral production enhance potential to prolong graft survival in pancreatic islet cell transplantation for the reversal of type 1 diabetes.
Kapturczak MH; Flotte T; Atkinson MA
Curr Mol Med; 2001 May; 1(2):245-58. PubMed ID: 11899074
[TBL] [Abstract][Full Text] [Related]
29. Identification and Validation of Small Molecules That Enhance Recombinant Adeno-associated Virus Transduction following High-Throughput Screens.
Nicolson SC; Li C; Hirsch ML; Setola V; Samulski RJ
J Virol; 2016 Aug; 90(16):7019-7031. PubMed ID: 27147738
[TBL] [Abstract][Full Text] [Related]
30. Recombinant AAV-mediated expression of galanin in rat hippocampus suppresses seizure development.
Lin EJ; Richichi C; Young D; Baer K; Vezzani A; During MJ
Eur J Neurosci; 2003 Oct; 18(7):2087-92. PubMed ID: 14622242
[TBL] [Abstract][Full Text] [Related]
31. Gene Therapy Repairs for the Epileptic Brain: Potential for Treatment and Future Directions.
Ahmad MA; Pottoo FH; Akbar M
Curr Gene Ther; 2020; 19(6):367-375. PubMed ID: 32003688
[TBL] [Abstract][Full Text] [Related]
32. Custom adeno-associated virus capsids: the next generation of recombinant vectors with novel tropism.
Muzyczka N; Warrington KH
Hum Gene Ther; 2005 Apr; 16(4):408-16. PubMed ID: 15871672
[TBL] [Abstract][Full Text] [Related]
33. Gene therapy with helper-dependent adenoviral vectors: lessons from studies in large animal models.
Brunetti-Pierri N; Ng P
Virus Genes; 2017 Oct; 53(5):684-691. PubMed ID: 28593513
[TBL] [Abstract][Full Text] [Related]
34. rAAV vector-mediated gene therapy for experimental ischemic stroke.
Li ZJ; Wang RZ
Neurol India; 2008; 56(2):116-21. PubMed ID: 18688133
[TBL] [Abstract][Full Text] [Related]
35. A normothermic ex vivo organ perfusion delivery method for cardiac transplantation gene therapy.
Bishawi M; Roan JN; Milano CA; Daneshmand MA; Schroder JN; Chiang Y; Lee FH; Brown ZD; Nevo A; Watson MJ; Rowell T; Paul S; Lezberg P; Walczak R; Bowles DE
Sci Rep; 2019 May; 9(1):8029. PubMed ID: 31142753
[TBL] [Abstract][Full Text] [Related]
36. Adeno-associated virus vectors: potential applications for cancer gene therapy.
Li C; Bowles DE; van Dyke T; Samulski RJ
Cancer Gene Ther; 2005 Dec; 12(12):913-25. PubMed ID: 15962012
[TBL] [Abstract][Full Text] [Related]
37. The future of epilepsy treatment: focus on adeno-associated virus vector gene therapy.
McCown TJ
Drug News Perspect; 2010 Jun; 23(5):281-6. PubMed ID: 20603651
[TBL] [Abstract][Full Text] [Related]
38. Recombinant adeno-associated virus as delivery vector for gene therapy--a review.
Lu Y
Stem Cells Dev; 2004 Feb; 13(1):133-45. PubMed ID: 15068701
[TBL] [Abstract][Full Text] [Related]
39. Impact of AAV Capsid-Specific T-Cell Responses on Design and Outcome of Clinical Gene Transfer Trials with Recombinant Adeno-Associated Viral Vectors: An Evolving Controversy.
Ertl HCJ; High KA
Hum Gene Ther; 2017 Apr; 28(4):328-337. PubMed ID: 28042943
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
